Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term fluorouracil. Found 29 abstracts

no pagination
Zijoo R, Olszanski AJ, Weinberg DS. Biomarkers and stage II colorectal cancer therapy. Translational Cancer Research. 2016 Jun;5:S84-S86.   PMCID: Editorial
Tang PA, Cohen SJ, Kollmannsberger C, Bjarnason G, Virik K, MacKenzie MJ, Lourenco L, Wang L, Chen A, Moore MJ. Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer. Clinical Cancer Research. 2012 Nov;18(21):6023-31.
Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(4):1367-75.   PMCID: PMC3208721
O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ. Assessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Initiative. Clinical Colorectal Cancer. 2011 Jun;10(2):113-6.   PMCID: PMC3388796
Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen CH. INITIAL RESULTS OF A PHASE I DOSE-ESCALATION TRIAL OF CONCURRENT AND MAINTENANCE ERLOTINIB AND REIRRADIATION FOR RECURRENT AND NEW PRIMARY HEAD-AND-NECK CANCER. International Journal of Radiation Oncology Biology Physics. 2010 Nov;78(4):1020-5.   PMCID: not NIH funded
Wong YN, Hamilton O, Egleston B, Salador K, Murphy C, Meropol NJ. Understanding How Out-of-Pocket Expenses, Treatment Value, and Patient Characteristics Influence Treatment Choices. The oncologist. 2010 Jan;15(6):566-76.   PMCID: PMCID: PMC2892556 [Available on 2011/1/1]
Earle CC, Weiser MR, Ter Veer A, Skibber JM, Wilson J, Rajput A, Wong YN, Benson AB, Shibata S, Romanus D, Niland J, Schrag D. Effect of Lymph Node Retrieval Rates on the Utilization of Adjuvant Chemotherapy in Stage II Colon Cancer. Journal of surgical oncology. 2009 Dec;100(7):525-8.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Rectal Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Meropol NJ. Turning point for colorectal cancer clinical trials. JOURNAL OF CLINICAL ONCOLOGY. 2006 Jul;24(21):3322-4.
Movsas B, Diratzouian H, Hanlon A, Cooper H, Freedman G, Konski A, Sigurdson E, Hoffman J, Meropol NJ, Weiner LM, Coia L, Lanciano R, Stein J, Kister D, Eisenberg B. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Oct;29(5):435-41.
Cohen SJ, Dobelbower Jr R, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. International Journal of Radiation Oncology Biology Physics. 2005 Jan;62(5):1345-50.
Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Journal of Clinical Oncology. 2004 Jul;22(14):2856-64.
Engstrom PF, Benson A, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, Martin EW, McGinn C, Petrelli NJ, Posey JA, Skibber JM, Venook A, Yeatman TJ. NCCN Practice Guidelines for colorectal cancer. Oncology-New York. 2000 Nov;14(11A):203-12.
Ho DH, Covington W, Brown N, Lin SN, Pazdur R, Huo YY, Creaven PJ, Rustum YM, Meropol NJ, Lassere Y, Kuritani J, Hayakawa T. Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer. Cancer Chemotherapy and Pharmacology. 2000 Nov;46(5):351-6.
Langer CJ. Induction or neoadjuvant therapy in resectable non-small cell lung cancer. Seminars in Oncology. 1999 Oct;26(5):34-9.
Meropol NJ, Rustum YM, Creaven PJ, Blumenson LE, Frank C. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: A potential role for growth factor as mucosal protectant. Cancer Investigation. 1999 Jan;17(1):1-9.
Berlin JD, Propert KJ, Trump D, Wilding G, Hudes G, Glick J, Burch P, Keller A, Loehrer P. 5-fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer - An Eastern Cooperative Oncology Group phase II study (E1889). American Journal of Clinical Oncology-Cancer Clinical Trials. 1998 Apr;21(2):171-6.
Hageboutros A, Hudes GR, Greene F, LaCreta FP, Brennan J, Odwyer PJ. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L- aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer. Investigational New Drugs. 1997 Jan;15(2):139-45.
Lattanzi JP, Coia LR, Scher RM, Engstrom PF, Hoffman JP, Eisenberg BF, Sigursdson ER, Epstein BE, Weiner LM. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver. Gi Cancer. 1997 Jan;2(2):111-7.
Hoffman JP, Odwyer P, Agarwal P, Salazar H, Ahmad N. Preoperative chemoradiotherapy for localized pancreatic carcinoma - A perspective. Cancer. 1996 Aug;78(3):592-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term fluorouracil

fluorouracil chemotherapy leucovorin trial oxaliplatin therapy 5-fluorouracil Oncology cancer advanced colorectal-cancer chemoradiotherapy radiotherapy 5- cisplatin colon-cancer bevacizumab colorectal-cancer Chemotherapy surgery colorectal-carcinoma 5-FU modulation adjuvant adjuvant chemotherapy survival rectal-cancer i Radiotherapy randomized trial combination sphincter preservation carcinoma cells pathological complete response Disease free survival time oral mucositis mitomycin-c squamous-cell carcinoma cetuximab enhancement prevention long-term survival bone-marrow transplantation schedule induction improves survival local excision phase-ii breast-cancer Tumors trials ii trial prognosis antiangiogenic therapy folinic acid Performance randomized-trial care Ftorafur(tegafur) plus cetuximab remission ii colon cancer preoperative chemoradiation family history curative resection acid pancreatic neoplasms hepatic carcinoma experience fluoropyrimidines Gerontologic oncology cost Quality Cancer adenocarcinoma GM-CSF plus irinotecan Rectal metastases preoperative radiotherapy pancreaticoduodenectomy Toxicity adriamycin uft radiation therapy NCCN Clinical Practice Guidelines hyperfractionated radiation toxicity Colon cancer cancer chemotherapy morbidity recovery prostate cancer LN retrieval hydroxyurea phase-i radiation-therapy Adenocarcinoma of the pancreas Reirradiation tumor-development Locally advanced capecitabine postoperative radiation-therapy organ preservation cell lung-cancer infusion 5-fluorouracil Patient treatment lymph-node metastases older diarrhea cancer staging antineoplastic willingness-to-pay solid UFT doxorubicin biochemical modulation cooperative-oncology-group tumors age External beam radiotherapy pancreas carcinoma irinotecan Diseases colorectal paclitaxel plus levamisole calcium leucovorin radiation effects Pancreatic cancer mitomycin C Community oncology chemoradiation dose leucovorin follow-up continuous-infusion 5-fluorouracil colorectal liver metastases neutropenia rectal neoplasms Neoadjuvant rectosigmoid carcinoma granulocyte-macrophage colony-stimulating tumor improvement kras circumferential resection margin pharmacology endothelial growth-factor iii
Last updated on Friday, December 06, 2019